AI | pharmaphorum

AI

Sales & Marketing

The 2025 way forward: What can UK healthcare advertising exp...

Buoyed by growth opportunities and the strengthening economy, 2024 turned out to be an interesting year for the United Kingdom’s (UK) healthcare advertising industry.

Oncology

Supercharging clinical trials with data and AI: Realyze’s Aa...

At ASCO 2025, Realyze CEO Aaron Brauser talks transforming clinical trial screening with AI, NLP and real-world data use.

Sales & Marketing

Just call it ‘good marketing’: Dan Gandor on why omnichannel...

A Q&A with EVERSANA's new Head of Omnichannel and Digital Transformation covers omnichannel, AI, pharma marketing headwinds, and more.

Digital

pharmaphorum podcast Episode 175a - Bill Grambley, AllazoHealth

Patients as active consumers of care: AI-driven personalisat...

In a new podcast, web editor Nicole Raleigh speaks with Bill Grambley, CEO of AllazoHealth, for a conversation on leveraging AI for marketing.

Sales & Marketing

KOL data for HCP engagement representation

Bad KOL data is expensive: Harnessing high-quality data for ...

As biopharmas increasingly rely on AI and advanced data-driven technologies, evaluating the quality of data is critical.

News

Representation of an Agentic AI platform

Axtria unveils transformational agentic AI platform for life...

Axtria today announced its next generation of Axtria InsightsMAx for life sciences, powered by agentic AI.

The 2025 way forward: What can UK healthcare advertising exp...

Supercharging clinical trials with data and AI: Realyze’s Aa...

Just call it ‘good marketing’: Dan Gandor on why omnichannel...

Patients as active consumers of care: AI-driven personalisat...

Bad KOL data is expensive: Harnessing high-quality data for ...

Axtria unveils transformational agentic AI platform for life...

NHS use of digital cardiac rehab tools endorsed

How to meet your physicians where they are online

AI

Editor's Picks